15 Oct
2021

Moderna’s covid-19 patent pledge may be backfiring

Moderna’s announcement that it will not share its know-how with the WHO’s new African vaccine tech transfer hub will attract more criticism of pharma IP owners in ongoing TRIPS waiver negotiations

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth